Sign in
CompletedPhase 4

The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Total Hip Arthroplasty

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
60 people enrolled
Started
1 Feb 2025
Ended
11 Jul 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • perineural Dexamethasone 4mg
  • intravenous Dexamethsone 4mg
Record updated
23 July 2025

Who can take part

Age
65 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • patients scheduled for total hip arthroplasty
  • patients aged >65 and <100 years
  • patients able to provide informed consent
  • patients able to reliably report symptoms to the research team

Who cannot take part

  • inability to provide first-party consent due to cognitive impairment or a language barrier
  • infection at the site of the regional block,
  • coagulation disorders,
  • history of regular steroid medication
  • immunodeficiency,
  • American Society of Anesthesiologists (ASA) physical status of IV or higher,

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the effect of the dexamethasone administration route (intravenous vs. perineural) on postoperative pain, inflammatory response, and clinical outcomes in patients undergoing total hip arthroplasty (THA) with a pericapsular nerve group (PENG) block. The primary outcome is the intensity of postoperative pain measured using the numerical rating scale (NRS) at rest and during movement. Secondary outcomes include the inflammatory response assessed by neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), opioid consumption, and patient satisfaction. The findings from this study may contribute to optimizing anesthesia protocols and improving postoperative recovery in patients undergoing THA.

The 2 groups in the trial

  • Perineural dexamethasoneExisting treatment, for comparison

    PENG block + perineural dexamethasone

    Treatment: perineural Dexamethasone 4mg

  • Intravenous dexamethasoneExisting treatment, for comparison

    PENG block + intravenous dexamethasone

    Treatment: intravenous Dexamethsone 4mg

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
23 July 2025